Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Heat Biologics, Inc. (NASDAQ: HTBX).

Full DD Report for HTBX

You must become a subscriber to view this report.

Recent News from (NASDAQ: HTBX)

Heat Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City
DURHAM, NC / ACCESSWIRE / August 29, 2018 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system against cancer, today announced it will present at the 20 th Annual Rodman & Renshaw Global Investment Conferenc...
Date: August, 29 2018 07:00
Heat Biologics Reports Second Quarter 2018 Results and Provides Corporate Update
Completed a capital raise of $20.7 million in the second quarter of 2018 On track to report key clinical milestones beginning in Q4 2018 DURHAM, NC / ACCESSWIRE / August 14, 2018 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activ...
Date: August, 14 2018 07:30


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on HTBX.

About Heat Biologics, Inc. (NASDAQ: HTBX)

Logo for Heat Biologics, Inc. (NASDAQ: HTBX)

Not available


Contact Information



    Current Share Structure

    • Market Cap: $6,513,582 - 05/16/2018
    • Issue and Outstanding: 3,578,891 - 01/22/2018


    Daily Technical Chart for (NASDAQ: HTBX)

    Daily Technical Chart for (NASDAQ: HTBX)

    Stay tuned for daily updates and more on (NASDAQ: HTBX)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: HTBX)

    Do your DD and if you choose, be ready to go!


    The Research: All source information contained in this email is from the public sources mentioned below.



    Thank you

    DD Report



    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in HTBX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of HTBX and does not buy, sell, or trade any shares of HTBX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: